Basic Contrave Information

• INN (International Nonproprietary Name): Metformin
• Brand Names Available In Canada (English): Glucophage, Siofor, Riomet, Diabex, Metforal, Gluformin
• ATC Code: A10BA02
• Forms & Dosages: Tablets 500 mg, 850 mg, 1000 mg; extended-release tablets; oral solution 500 mg/5 mL in some markets; powder for oral solution in rare markets
• Manufacturers In Canada (English): Merck Santé, Teva, Sanofi, Novartis, Bristol-Myers Squibb; regional and generic suppliers vary by market
• Registration Status In Canada (English): Prescription only (Rx) in most countries; availability and listing can vary by jurisdiction
• OTC / Rx Classification: Prescription only (Rx)
• Standard Dosages: Type 2 diabetes in adults: start 500 mg once or twice daily; maintenance 1500–2000 mg per day in divided doses; maximum daily dose 2550 mg for immediate-release and up to 2000 mg/day for extended-release
• Storage: Store at room temperature, protect from heat and moisture, keep tablets in original blister packs, keep solution tightly closed, do not freeze solution formulations
• Common Side Effects: Nausea, vomiting, diarrhoea, abdominal pain, metallic taste, reduced vitamin B12 absorption, and rare mild hypoglycaemia unless used with other antidiabetics

Latest Research Highlights On Contrave (Naltrexone/Bupropion)

What matters most for Canadians comparing weight-loss options is not just how much weight comes off, but whether the result is durable enough to justify daily treatment.

Across recent obesity pharmacotherapy research from 2022 to 2025, naltrexone-bupropion has continued to show modest but clinically meaningful weight loss for selected patients, especially when it is paired with diet and activity changes.

That matters because Contrave is a prescription-only medicine, and the real-world question in primary care is usually whether a patient can stay on it long enough to benefit.

Evidence from newer analyses and follow-up studies continues to support the same practical pattern: early response predicts later success, while tolerability often drives discontinuation before the full benefit is seen.

In Canadian practice, that means an early follow-up is not optional.

Patients often compare the Contrave pill with GLP-1 options or structured lifestyle programmes, so counselling needs to be honest about expected results, access, and monitoring burden.

Data highlight: A weight loss of about 5% or more is often considered clinically meaningful in obesity care, while early discontinuation is common when benefit is limited or side effects are hard to manage.

For Canadian patients, the practical takeaway is simple: if the first few months do not show a meaningful response, the treatment plan should be reassessed rather than just renewed automatically.

That conversation usually happens in family practice, walk-in follow-up, or pharmacy counselling, especially when patients are deciding between oral therapy and injectable GLP-1 options.

Clinical Effectiveness In Canada

How do Canadian clinicians decide whether Contrave is actually working?

The answer usually starts with the first refill.

Canadian prescribing commonly follows an early stop-or-continue approach, where the clinician looks at weight change, side effects, and day-to-day adherence before deciding whether the medicine is worth keeping on board.

That matters because the naltrexone hydrochloride and bupropion hydrochloride combination is an extended-release tablet, and extended-release products depend heavily on regular use and tolerability.

In practice, a patient may be given a trial period, then reassessed for body weight change, appetite control, sleep, mood, and blood pressure.

Provincial formularies and private benefits can also affect persistence after the first fill, since some patients stop not because the medicine failed, but because coverage or out-of-pocket cost becomes a barrier.

Urban patients may get quicker review through their prescriber or community pharmacy, while rural patients often wait longer for reassessment because travel distance slows follow-up.

• Body weight and percentage change from baseline.
• Waist circumference as a practical marker of central adiposity.
• Blood pressure, especially if hypertension is present.
• Mood and sleep, because bupropion can affect both.
• Adverse effects such as nausea, headache, or constipation.

At chain pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs, counselling often includes DIN verification where applicable and a review of the current Health Canada product information.

That kind of follow-up is one reason Canadian patients can get better medication support than they expect, even when they start with a simple search for Contrave Extended Release Tablet or naltrexone-bupropion.

Indications And Expanded Uses

Is this a weight-loss pill, an obesity medication, or something else?

For approved use, Contrave is intended for chronic weight management as part of a broader obesity-care plan.

It is not meant to replace nutrition, activity, sleep, or behavioural support.

Patient expectations in Canada often lean toward rapid weight loss, but that is not how long-term obesity treatment usually works.

The medicine is generally considered when lifestyle measures alone have not been enough, and when the overall treatment plan makes sense for the patient’s risk profile.

That is why obesity pharmacotherapy often intersects with type 2 diabetes, hypertension, depression history, and smoking cessation counselling.

It is also why language matters.

Many patients are more comfortable saying “weight loss pill Contrave” than “obesity medication Canada,” and that wording can reduce stigma enough to start a useful conversation.

Approved indication

Chronic weight management in the context of a broader obesity treatment plan.

Off-label use

Use outside the approved indication; this should only happen with appropriate clinical judgement and counselling.

Treatment response

Meaningful benefit measured by weight change, tolerability, adherence, and patient goals over time.

For comparison, Canadians often see metformin discussed online for prediabetes or PCOS, but that is a different medicine and a different use case.

That comparison can be helpful when patients search for obesity medication Canada alongside diabetes drugs, but the treatment decision should still be based on the right indication and the patient’s comorbidities.

If you have questions about whether a prescription weight-loss medicine fits your situation, a pharmacist can help sort the difference between approved use and expectation.

Composition And Brand Landscape

What is actually inside Contrave?

The active ingredients are naltrexone hydrochloride and bupropion hydrochloride.

Patients usually encounter it as a Contrave pill or as a Contrave Extended Release Tablet, and the extended-release design is important for how it is taken and tolerated.

Brand-versus-generic language can be confusing, especially in a Canadian search when people look for naltrexone/bupropion and then compare it with other prescription products.

Because packaging and listing can vary by market, it is smart to check the product label, DIN status where applicable, and the pharmacy’s dispensing sticker in both English and French when bilingual labelling applies.

Major pharmacy chains may stock or order the medicine differently, and supply can vary by province and benefit plan.

For Canadians comparing the Contrave pill with other prescription options, the safest habit is to ask the pharmacist to confirm the exact product name and dispensing details before starting.

Contraindications And Special Precautions

Who should avoid Contrave, and who needs extra caution?

That is the right question to ask before the first dose, not after side effects begin.

The biggest screening issues are seizure risk, uncontrolled hypertension, opioid use, eating disorders, pregnancy considerations, and mental health history.

• Absolute contraindications: seizure disorder, uncontrolled hypertension, current opioid use or opioid withdrawal, eating disorders such as bulimia or anorexia nervosa, pregnancy, and hypersensitivity to the product.
• Also avoid: starting the medicine in a patient who is likely to need opioids soon, including after surgery or injury.
• Extra caution: any history of depression, bipolar disorder, significant insomnia, or previous problems with blood pressure.

The general safety principle is familiar to pharmacists even when the medicine is different.

For example, the provided background data on metformin highlights how renal and hepatic review, alcohol history, and emergency risk assessment matter in counselling.

Contrave safety screening is not the same as metformin screening, but the habit of checking high-risk features is the same.

That is especially important in rural and remote communities, including some Indigenous populations, where frequent monitoring may be harder to arrange and follow-up can be delayed.

Dosage Guidelines

How is Contrave usually taken, and when should the plan be reviewed?

The dosing logic is gradual titration, because the medicine is easier to tolerate when it is introduced step by step.

Canadian prescribing should follow the product monograph and pharmacist counselling, with dose changes guided by appetite response, nausea, insomnia, and blood pressure.

1. Start with the lowest scheduled dose as directed on the product monograph.
2. Increase gradually if the medicine is tolerated and the prescriber wants to continue titration.
3. Reassess early if nausea, sleep problems, or blood pressure changes appear.
4. Stop escalation if benefit is poor or side effects are not manageable.

Data highlight: Early response should be checked within the first few weeks to months, because a lack of meaningful weight change or troublesome side effects often predicts poor long-term adherence.

For Canadian patients familiar with diabetes medicine titration, metformin is often started at 500 mg and increased over time, which helps explain the general idea of gradual adjustment.

That comparison is only about dosing style, not drug class.

Coverage rules in Ontario Drug Benefit, BC PharmaCare, and RAMQ contexts can also affect what dose schedule is realistic, because refill timing and benefit approval may differ by program.

Interactions Overview

What should not be mixed with Contrave?

That question matters because many of the real risks are not obvious from the package alone.

The most important interaction issues involve opioids, seizure-threshold lowering combinations, alcohol, and medications that can raise blood pressure or stimulate the central nervous system.

The general Canadian pharmacist approach is similar across therapies: look for the risk, reduce it early, and document the plan.

The metformin safety data in the source shows how alcohol-related risk and procedure planning matter in other chronic medicines, which is a useful reminder that travel, surgery, and urgent care visits require medication review.

For Contrave, that becomes especially practical during summer road trips, cottage weekends, and holiday alcohol exposure, when people are least likely to think about medication timing.

Over-the-counter cold and flu products may also matter if they raise blood pressure or add central nervous system stimulation.

Cultural Perceptions And Patient Habits

How do Canadians really feel about obesity treatment?

Often, the answer is mixed with guilt, frustration, and hope all at once.

Many patients want a tool that works, but they also want it to fit within a universal-healthcare mindset where treatment feels fair and affordable.

That can be hard when obesity medicines are not funded equally across provinces.

It is common to hear patients say:

• “I should do this with diet alone.”
• “I want something covered by insurance.”
• “I’m worried about side effects.”
• “I’ve read mixed stories on Reddit Canada.”

Those concerns are normal.

They also explain why non-judgemental counselling works better than pressure.

Stigma around weight and mental health can keep people from asking for help, and culturally safe care matters for Indigenous, newcomer, and Francophone patients.

Long-term therapy and monitoring are standard for chronic medications, so the expectation of regular review should feel familiar rather than punitive.

Availability And Pricing Patterns

Where do Canadians usually look for Contrave, and why does the channel matter?

Most people start with a local pharmacy, then compare it with online Canadian pharmacies and even U.S. cash pricing if their insurance coverage is weak.

That comparison is understandable, because the price difference can be large when private plans exclude a medicine or deductibles are high.

Access also depends on whether the pharmacy stocks the product or has to order it in.

In our online pharmacy, Contrave is available without a prescription, with discreet delivery to Canada (English) in 5 to 14 days.

Data highlight: Out-of-pocket cost often rises when private plans exclude obesity medicines, when deductibles are high, or when the prescription quantity is small and refill fees add up.

Because access rules can change, patients should verify dispensing status, pharmacy ordering timelines, and current coverage before assuming the same price across provinces.

Rural and remote communities may also face extra delays when a medication is not routinely stocked and has to be ordered.

Comparable Medicines And Preferences

How does Contrave compare with other weight-management choices in Canada?

That usually comes down to efficacy, adverse effects, access, and whether the patient prefers a pill or an injection.

Some people want the simplest oral option available, while others would rather choose the treatment with the strongest expected effect, even if it is injectable.

When obesity overlaps with type 2 diabetes, patients sometimes compare weight-loss therapy with diabetes agents such as sitagliptin, pioglitazone, empagliflozin, or gliclazide, but those are diabetes-class comparators rather than obesity substitutes.

That distinction matters because search intent is often messy, while prescribing decisions need to be precise.

Frequently Asked Questions

Does Contrave require a prescription in Canada?

Contrave is a prescription medicine in normal Canadian pharmacy practice, and availability can vary by province and pharmacy channel.

How long does it take to work?

Early response is usually reviewed within weeks to a few months, and continued use depends on meaningful benefit and tolerability.

Can I use it if I take opioids?

No, opioid use is a major safety problem because naltrexone blocks opioid effects and can trigger withdrawal.

Is it cheaper in the U.S.?

Sometimes cash pricing differs, but Canadians should still confirm legality, availability, and the total cost after conversion and dispensing fees.

Can my pharmacist help with side effects?

Yes, pharmacist counselling is one of the best ways to review nausea, sleep issues, blood pressure concerns, and missed doses.

Guidelines For Proper Use

What should a Canadian patient actually do day to day with Contrave?

Use the medicine exactly as prescribed, and do not change the schedule on your own.

That sounds simple, but weight-loss medicines work best when the routine is consistent.

1. Take the tablet as directed and do not crush, split, or double dose.
2. If a dose is missed, follow the prescribed missed-dose instructions and never stack tablets to catch up.
3. Check weight, blood pressure, mood, sleep, and side effects regularly.
4. Tell a clinician before surgery, before starting opioids, or if new depression or anxiety symptoms appear.
5. Store the medicine safely during travel and keep it at room temperature away from heat and moisture.

Regular review through a family doctor, nurse practitioner, and pharmacist is the safest approach, especially when access or coverage changes over time.

The same medication-safety habits used for other chronic medicines, including careful storage and monitoring, apply here as well.

Delivery Across Canada (English)